Evidence map›Paper›PMID 41584582›Full record

ArticleFrontiers in oncology2025

Machine learning models based on log odds of positive lymph nodes for predicting survival in T

Yuchen Liu, Hao Cui, Zhen Yuan, Jinghang Wang, Ruonan An, Rui Li, Jianxin Cui, Bo Wei

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi-Omics and Machine Learning.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuchen Liu *School of Medicine, Nankai University, Tianjin, China.
Hao Cui *School of Medicine, Nankai University, Tianjin, China.
Zhen YuanSchool of Medicine, Nankai University, Tianjin, China.
Jinghang WangSchool of Medicine, Nankai University, Tianjin, China.
Ruonan AnSchool of Medicine, Nankai University, Tianjin, China.
Rui LiSchool of Medicine, Nankai University, Tianjin, China.
Jianxin CuiSchool of Medicine, Nankai University, Tianjin, China.
Bo WeiSchool of Medicine, Nankai University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although early gastric cancer (EGC) is generally limited to the mucosal and submucosal layers, lymph node metastasis can still occur, which may worsen the prognosis, particularly when the number of examined lymph nodes (ELNs) is inadequate. This study introduces log odds of positive lymph nodes (LODDS) as a prognostic factor and integrates it with machine learning to improve survival predictions in T Methods: This retrospective study used data from the Surveillance, Epidemiology, and End Results (SEER) Program and an independent validation cohort from the Chinese People's Liberation Army General Hospital First Medical Center. Predictive factors were selected using LASSO regression and multivariate Cox regression. Cox proportional-hazards (CoxPH), random survival forest (RSF), and XGBoost models were developed to predict overall survival (OS). Model interpretability and feature importance were evaluated using the SHapley Additive exPlanations (SHAP) method. Results: A total of 419 T Conclusions: Integrating LODDS staging into the RSF model, alongside other clinical features, provides a highly accurate tool for survival prediction in T

Indexed as

early gastric cancerLODDS staginglymph node metastasismachine learningprognosis

Identifiers

PMID41584582
PMCPMC12827109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.